Cingulate Inc. Warrants Share Price

Cingulate Inc. Warrants Share Price

NASDAQ: CINGW | Micro Cap
$0.00
+$0.00 (--%) Last updated on 18 Nov, 2026 | 00:05 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cingulate Inc. Warrants Stock Performance

Open
$0.00
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.00 - $0.00
Year Range
$0.00 - $0.08
Volume
901
Average Traded
$0.00

Cingulate Inc. Warrants Share Price Chart

Line chart of the Cingulate Inc. Warrants price trend over the selected period. The price rose overall, ranging from 0.00 to 0.00, ending at 0.00.
$0.00$0.00
L
Show Current Price
H

Cingulate Inc. Warrants Stock Fundamentals & Key Indicators

Market Cap
$17188.12
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
-140.54%
Profit Margin
N/A
Debt to Equity
0.16
Quarterly Earnings Growth YoY
-23.29%

Cingulate Inc. Warrants Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$6.27-$9.31-$5.87-$7.73
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-48.48%36.95%-31.69%

Cingulate Inc. Warrants Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.68-$23.53-$16.56-$22.45
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-33.09%29.62%-35.57%

About Cingulate Inc. Warrants

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Cingulate Inc. Warrants Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.00
$0.00
-40.00%
Oct 2026
$0.01
$0.01
-37.50%
Aug 2026
$0.01
$0.01
-83.67%
Feb 2026
$0.07
$0.05
-2.00%
Jan 2026
$0.05
$0.05
-37.50%
Dec 2025
$0.08
$0.08
+60.00%
Oct 2025
$0.05
$0.05
+0.00%
Aug 2025
$0.06
$0.05
-21.87%
Jul 2025
$0.06
$0.06
+0.00%
Jun 2025
$0.04
$0.06
+16.36%
May 2025
$0.04
$0.06
+25.00%
Apr 2025
$0.06
$0.04
-16.98%

CINGW Share Price FAQs